Abnormalities in glucose tolerance are common in children with Fanconi anemia and associated with impaired insulin secretion

Pediatric Blood and Cancer

Volumn 51, Issue 2, 2008, Pages 256-260

  Elder, Deborah A ^a   D'Alessio, David A ^b   Eyal, Ori ^a   Mueller, Robin ^c   Smith, Franklin O ^c   Kansra, Alvina R ^a   Rose, Susan R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c Fanconi Anemia Comprehensive Care Center   (United States)

Author keywords

Fanconi anemia; HOMA IR; IFG; IGT; Insulin secretion; Insulin sensitivity; Insulinogenic index

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CELL FUNCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FANCONI ANEMIA; FEMALE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; GLUCOSE TOLERANCE TEST; INFANT; METABOLISM; PRESCHOOL CHILD; SECRETION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FANCONI ANEMIA; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INFANT; INSULIN; INSULIN RESISTANCE; MALE;

EID: 45549109339     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21589     Document Type: Article

References (21)

1. Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001;107:744-754.
2. Giampietro PF, Verlander PC, Davis JG, et al. Diagnosis of Fanconi anemia in patients without congenital malformations: An international Fanconi Anemia Registry Study. Am J Med Genet 1997;68:58-61.
3. Fanconi Anemia Standards for Clinical Care: Fanconi Anemia Research Fund, Inc; 2003.
4. John PR, Thuluvath PJ. Outcome of patients with new-onset diabetes mellitus after liver transplantation compared with those without diabetes mellitus. Liver Transpl 2002;8:708-713.
5. Roth D, Milgrom M, Esquenazi V, et al. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation 1989;47:278-281.
6. Phillips DI, Clark PM, Hales CN, et al. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994;11:286-292.
7. Shalitin S, Phillip M, Stein J, et al. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2006;37:1109-1117.
8. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 1993;21:731-733.
9. Elder DA, Prigeon RL, Wadwa RP, et al. Beta-cell function, insulin sensitivity, and glucose tolerance in obese diabetic and nondiabetic adolescents and young adults. J Clin Endocrinol Metab 2006;91:185-191.
10. American Diabetes Association. Standards of medical care in diabetes - 2007. Diabetes care 2007;30:S4-S41.
11. Morrell D, Chase CL, Kupper LL, et al. Diabetes mellitus in ataxia-telangiectasia, Fanconi anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes 1986;35:143-147.
12. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672.
13. Cutfield WS, Hofman PL. Simple fasting methods to assess insulin sensitivity in childhood. Horm Res 2005;64:25-31.
14. Wareham NJ, Phillips DI, Byrne CD, et al. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995;12:931.
15. Giri N, Batista DL, Alter BP, et al. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007;92:2624-2631.
16. Swift M, Sholman L, Gilmour D. Diabetes mellitus and the gene for Fanconi's anemia. Science (New York, NY) 1972;178:308-310.
17. Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001;86:4047-4058.
18. Greenbaum CJ, Prigeon RL, D'Alessio DA. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. Diabetes 2002;51:951-957.
19. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 1996;20:463-466.
20. Sigfrid LA, Cunningham JM, Beeharry N, et al. Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line. J Mol Med (Berlin, Germany) 2004;82:325-335.
21. Pagano G, Youssoufian H. Fanconi anaemia proteins: Major roles in cell protection against oxidative damage. Bioessays 2003;25:589-595.